.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Chinese Patent Office
US Army
Cerilliant
Covington
Healthtrust
Mallinckrodt
Fish and Richardson
UBS

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207620

« Back to Dashboard
NDA 207620 describes ENTRESTO, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are six patents protecting this drug. Additional details are available on the ENTRESTO profile page.

The generic ingredient in ENTRESTO is sacubitril; valsartan. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the sacubitril; valsartan profile page.

Summary for NDA: 207620

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 207620

Mechanism of ActionNeprilysin Inhibitors
Angiotensin 2 Receptor Antagonists

Suppliers and Packaging for NDA: 207620

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ENTRESTO
sacubitril; valsartan
 TABLET;ORAL 207620 NDA Novartis Pharmaceuticals Corporation 0078-0659 0078-0659-20 60 TABLET, FILM COATED in 1 BOTTLE (0078-0659-20)
ENTRESTO
sacubitril; valsartan
 TABLET;ORAL 207620 NDA Novartis Pharmaceuticals Corporation 0078-0659 0078-0659-35 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0078-0659-35) > 1 TABLET, FILM COATED in 1 BLISTER PACK (0078-0659-61)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength24MG;26MG
Approval Date:Jul 7, 2015TE:RLD:Yes
Patent:7,468,390Patent Expiration:Nov 27, 2023Product Flag?YSubstance Flag?Delist Request?
Patent:8,101,659Patent Expiration:Jan 14, 2023Product Flag?YSubstance Flag?Delist Request?
Patent:8,404,744Patent Expiration:Jan 14, 2023Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
US Army
Healthtrust
US Department of Justice
McKinsey
Fuji
Citi
McKesson
Julphar
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot